Integrated Wellness SPAC delisted, $14.7M trust backs Btab deal amid going-concern risk

Integrated Wellness Acquisition Corp (NYSE: WEL-WT)

Quick read: This is a blank‑check (SPAC) that hasn't started operations. Management is pursuing a business combination with Btab Ecommerce Group, Inc. The company was delisted from the NYSE in Dec 2024 and now trades OTC. Most cash sits in the Trust Account; operating cash outside the trust is effectively exhausted and the company reports substantial doubt about its ability to continue as a going concern.

Key facts & statistics (as reported)
* Total assets: $14,771,649.
* Cash outside Trust Account: $4,030.
* Restricted cash / Trust Account: $14,765,219.
* Total liabilities: $12,148,525.
* Shareholders' deficit: $(12,142,095); Accumulated deficit: $(12,142,383).
* Promissory note - Suntone: $3,407,063; Promissory note - related party: $1,790,000.
* Deferred underwriter's fee payable: $4,025,000.
* Accrued expenses: $2,268,760; Accounts payable: $424,473; Due to related party: $233,229.
* Q2 2025 operating expenses (three months): $140,344; loss from operations: $(140,344).
* Interest earned on Trust (three months): $115,991; Net loss Q2 2025: $(24,353).
* Six months ended June 30, 2025: operating expenses $546,022; interest on Trust $229,168; net loss $(316,854).
* Weighted-average redeemable Class A shares used for EPS: 1,185,481; Class A basic/diluted net income per share (Q2 2025): $0.16 (accounting allocation effect).
* Working capital deficit: ~$8.12 million (reported).

What's happening inside
* Management completed a Sponsor handover to Sriram/Suntone (Feb 1, 2024). Suntone has funded extension-related obligations and holds significant promissory note balances recorded as liabilities.
* The company signed an amended Business Combination Agreement with Btab (Aug 26, 2024) - target equity value cited at $250,000,000 payable in Pubco shares upon closing (subject to approvals and adjustments).
* The NYSE suspended/delisted the company's securities (Dec 2024); trading moved to OTC market. NYSE filed Form 25 to delist on Jan 2, 2025.
* The Trust Account still holds most sponsor/IPO proceeds and generates interest income, which offsets public operating expenses in part.

Positive aspects (income statement & company position)
* Large Trust Account balance provides the capital base for a potential business combination: Trust ≈ $14.7M.
* Interest income is meaningful relative to operating costs: Q2 interest on Trust $115,991 vs. op. expenses $140,344 (partially offsets cash burn).
* Sponsor / affiliate support continues via promissory notes and extension payments - they have funded required extension deposits and working capital advances.

Negative aspects (income statement & risks)
* Operating losses persist: six‑month operating expenses $546,022 vs. interest income $229,168 - company still net loss negative $(316,854) YTD.
* Cash outside the Trust is essentially zero ($4,030) - limited liquidity to fund transaction closing costs without further sponsor funding or conversion of promissory notes.
* Large liabilities tied to sponsor loans and deferred fees (promissory notes $5.2M aggregate; deferred underwriter fee $4,025,000) increase leverage and reduce net value available to public shareholders on a liquidation or transaction.
* Material weaknesses in disclosure/internal controls remain - reported control deficiencies related to cash flow classification and accounting for complex transactions.
* Delisting from NYSE increases execution risk, reduces liquidity and investor confidence; warrants may become worthless if no business combination by termination date.
* Company discloses "substantial doubt" about ability to continue as a going concern without additional sponsor/third‑party financing.

Implications for investors
* The Trust Account provides downside protection for public shareholders who redeem in a completed deal or liquidation, but the reported redemption balances and deferred fees reduce the per‑share cash available.
* Class A EPS appears positive due to accounting allocations and accretion to redemption value - this is a technical result and does not reflect operating profitability.
* Key near‑term risks to monitor: approval/closing of the Btab transaction, further sponsor funding or conversion of promissory notes, any further redemptions or litigation, and remediation of internal control weaknesses.

Bottom line: Integrated Wellness Acquisition Corp is a SPAC with the bulk of value tied to its Trust Account and a pending business combination with Btab. Interest income helps but does not cover operating costs; outside‑trust liquidity is negligible and sponsor funding/notes are substantial. The company faces execution and governance risks (delisting, material weaknesses, going‑concern disclosure). Investors should treat reported per‑share "income" for Class A as an accounting allocation artifact and focus on transaction mechanics, timing, and sponsor support.